Found: 17
Select item for more details and to access through your institution.
Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00965-w
- By:
- Publication type:
- Article
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
- Published in:
- Nature Medicine, 2014, v. 20, n. 10, p. 1130, doi. 10.1038/nm.3665
- By:
- Publication type:
- Article
Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 6, p. 843, doi. 10.1111/bjh.15490
- By:
- Publication type:
- Article
Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 574, doi. 10.1111/bjh.13613
- By:
- Publication type:
- Article
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.
- Published in:
- Nature Genetics, 2013, v. 45, n. 2, p. 186, doi. 10.1038/ng.2508
- By:
- Publication type:
- Article
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 22, p. 6761, doi. 10.3390/jcm11226761
- By:
- Publication type:
- Article
MDS-029: Prevalence of VEXAS Syndrome in MDS/CMML Patients with Systemic Inflammatory and Auto-Immune Disease.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S337, doi. 10.1016/S2152-2650(21)01788-2
- By:
- Publication type:
- Article
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02053-4
- By:
- Publication type:
- Article
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00734-1
- By:
- Publication type:
- Article
Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.29905
- By:
- Publication type:
- Article
Transforming potential of the T‐cell acute lymphoblastic leukemia‐associated homeobox genes HOXA13, TLX1, and TLX3.
- Published in:
- Genes, Chromosomes & Cancer, 2006, v. 45, n. 9, p. 846, doi. 10.1002/gcc.20348
- By:
- Publication type:
- Article
Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML).
- Published in:
- Biomedicines, 2021, v. 9, n. 11, p. 1704, doi. 10.3390/biomedicines9111704
- By:
- Publication type:
- Article
A novel high-risk subtype of B-ALL defined by CDX2 ectopic expression and UBTF::ATXN7L3 fusion<sup> 1 </sup>.
- Published in:
- Hematologie, 2022, v. 28, n. 4, p. 177, doi. 10.1684/hma.2022.1760
- By:
- Publication type:
- Article
Paysage génomique des leucémies aiguës lymphoblastiques B de l'adulte.
- Published in:
- Hematologie, 2018, v. 24, n. 6, p. 357, doi. 10.1684/hma.2019.1401
- By:
- Publication type:
- Article
B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH -Rearranged B-ALL.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01374
- By:
- Publication type:
- Article